ASPSCR1 and alveolar soft part sarcoma: Strong nuclear TFE3 immunoreactivity, resulting from the ASPSCR1-TFE3 gene fusion, serves as a diagnostic hallmark and represents a critical molecular feature distinguishing ASPS from histologic mimics (2).